| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Prod Dev &Med Aff &CMO | EVP, Chief Development Officer | CMO, Immuno-oncology
3 companies
Peterson Amy C. serves as an EVP Prod Dev &Med Aff &CMO at EXEL and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 0 buys and 41 sells. Those positions are worth an estimated $21.3M at current prices.
Historically, Peterson Amy C.'s trades have earned a below-average insider score of 41/100 across 3 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -11.9%.
The biggest single holding is EXEL (~$21.2M) as EVP Prod Dev &Med Aff &CMO. The recent filings there lean toward selling, a net 72,776 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | EXEL Exelixis, Inc. | EVP Prod Dev &Med Aff &CMO | Sale+OE | 72,776 | $45.47 | $3,309,124.72 | -13.5% | -15.3% | +10.4% | |
| Mar 16, 2023 | CTMX Cytomx Therapeutics, Inc. | EVP, Chief Development Officer | Sell | 4,257 | $1.98 | $8,424.60 | -6.8% | -19.1% | +6.7% | |
| Jul 20, 2022 | CTMX Cytomx Therapeutics, Inc. | EVP, Chief Development Officer | Sell | 7,463 | $1.42 | $10,612.39 | -10.6% | -6.6% | +18.5% | |
| Dec 18, 2018 | ONC Beone Medicines Ltd. | CMO, Immuno-oncology | Sale+OE | 20,000 | $133.68 | $2,673,536.07 | - | - | - | |
| Nov 12, 2018 | ONC Beone Medicines Ltd. | CMO, Immuno-oncology | Sale+OE | 40,000 | $120.20 | $4,808,089.13 | - | - | - | |
| Aug 23, 2018 | ONC Beone Medicines Ltd. | CMO, Immuno-oncology | Sell | 5,769 | $169.12 | $975,666.46 | -100% | - | - | |
| Nov 13, 2017 | ONC Beone Medicines Ltd. | CMO, Immuno-oncology | Sell | 3,601 | $82.96 | $298,747.11 | -100% | - | - |